Kevin J. Cameron - 09 Apr 2026 Form 4 Insider Report for Ionetix Corp / DE /

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 May 2026, 14:25:43 UTC
Prior SEC filing
05 Nov 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phieu Phun, as Attorney-in-Fact for Kevin J Cameron

Key filing fact

Kevin J. Cameron filed Form 4 for Ionetix Corp / DE / on 13 May 2026.

Key facts

  • This page summarizes Kevin J. Cameron's Form 4 filing for Ionetix Corp / DE /.
  • 9 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 13 May 2026, 14:25.

Change

  • Previous filing in this sequence was filed on 05 Nov 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001398422 Primary reporting owner

Cameron Kevin J

Relationship
President and CEO
Address
C/O IONETIX CORPORATION, 3130 SOVEREIGN DRIVE, LANSING
Signature
/s/ Phieu Phun, as Attorney-in-Fact for Kevin J Cameron
Signature date
13 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker transaction

Common Stock

Award

Transaction value
Shares
+5,306,782
Change %
Price
Shares after
5,306,782
Date
09 Apr 2026
Ownership
Direct
Footnotes
F1
No ticker transaction

Common Stock

Award

Transaction value
Shares
+205,932
Change %
Price
Shares after
205,932
Date
09 Apr 2026
Ownership
By daughter
Footnotes
F1, F2
No ticker transaction

Common Stock

Award

Transaction value
Shares
+206,209
Change %
Price
Shares after
206,209
Date
09 Apr 2026
Ownership
By son
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+501,400
Change %
Price
Shares after
501,400
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
501,400
Exercise price
$0.3200
Footnotes
F3, F4
No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+334,266
Change %
Price
Shares after
334,266
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
334,266
Exercise price
$0.3800
Footnotes
F3, F4
No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+162,955
Change %
Price
Shares after
162,955
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
162,955
Exercise price
$0.6200
Footnotes
F3, F4
No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+162,955
Change %
Price
Shares after
162,955
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
162,955
Exercise price
$0.6200
Footnotes
F4, F5
No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+162,955
Change %
Price
Shares after
162,955
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
162,955
Exercise price
$0.9800
Footnotes
F4, F6
No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+162,955
Change %
Price
Shares after
162,955
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
162,955
Exercise price
$0.9800
Footnotes
F4, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Received in connection with the Issuer's merger (the "Merger") with Ionetix Corporation ("Legacy Ionetix") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated as of April 9, 2026 (the "Merger Agreement"), by and among the Issuer (f/k/a JDEV Acquisition Corp.), JDEV Merger Subsidiary and Legacy Ionetix. Pursuant to the terms of the Merger Agreement, each outstanding share of Legacy Ionetix common stock was entitled to receive 0.5014 (the "Conversion Ratio") shares of the Issuer's Common Stock. The Merger closed on April 9, 2026.

Footnote F2

The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Footnote F3

The stock option is fully vested and exercisable.

Footnote F4

Received in connection with the Merger in exchange for options to acquire shares of Legacy Ionetix common stock adjusted by the Conversion Ratio.

Footnote F5

The stock option vests in 48 monthly installments beginning on January 15, 2025.

Footnote F6

The stock option vests in 48 monthly installments beginning on March 27, 2026.

Footnote F7

The stock option vests in 48 monthly installments beginning on March 17, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .